C14 performance rose from 76% in the 2025 Star Ratings to 79% in 2026, while the 4-Star threshold moved down from 84%, so cut points and performance shifted in opposite directions this year. The measure scores the most recent qualifying blood pressure of the measurement year below 140/90 mm Hg, with both systolic and diastolic values required to meet it. An order, a medication change, or a documented follow-up plan creates no numerator credit on its own, which makes the measure sensitive to in-visit measurement technique and to which reading ends up as the last one on file.
AAVBC's Controlling Blood Pressure Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering the HEDIS CBP specification and measure-defined exclusions, why the most recent eligible reading governs rather than the best one, repeat-measurement technique and coding reference, clinical prioritization for outreach, system and workflow barriers, equitable access and differences in blood-pressure control, SOAP-format documentation optimization, and the distinction between the measure threshold and an individualized treatment target. Grounded in current CMS and 2025 AHA/ACC hypertension guidance, this guide supports consistent, individualized clinical decision-making, helping care teams convert accurate measurement into controlled blood pressure, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of C14 performance — moving far beyond quick-reference essentials. These guides provide an integrated review of measurement importance and impact, clinical integrations, technical details, challenges and barriers, strategies for team coordination and quality improvement as well as regulatory and financial considerations. The Deep-Dives combine evidence-informed clinical guidance with practical operational tools to support a deeper understanding of C14 performance and provide care teams with strategies to thrive within a value-based model.
C14 performance rose from 76% in the 2025 Star Ratings to 79% in 2026, while the 4-Star threshold moved down from 84%, so cut points and performance shifted in opposite directions this year. The measure scores the most recent qualifying blood pressure of the measurement year below 140/90 mm Hg, with both systolic and diastolic values required to meet it. An order, a medication change, or a documented follow-up plan creates no numerator credit on its own, which makes the measure sensitive to in-visit measurement technique and to which reading ends up as the last one on file.
AAVBC's Controlling Blood Pressure Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering the HEDIS CBP specification and measure-defined exclusions, why the most recent eligible reading governs rather than the best one, repeat-measurement technique and coding reference, clinical prioritization for outreach, system and workflow barriers, equitable access and differences in blood-pressure control, SOAP-format documentation optimization, and the distinction between the measure threshold and an individualized treatment target. Grounded in current CMS and 2025 AHA/ACC hypertension guidance, this guide supports consistent, individualized clinical decision-making, helping care teams convert accurate measurement into controlled blood pressure, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of C14 performance — moving far beyond quick-reference essentials. These guides provide an integrated review of measurement importance and impact, clinical integrations, technical details, challenges and barriers, strategies for team coordination and quality improvement as well as regulatory and financial considerations. The Deep-Dives combine evidence-informed clinical guidance with practical operational tools to support a deeper understanding of C14 performance and provide care teams with strategies to thrive within a value-based model.
